文献速递造血干细胞移植与细胞治疗

自噬可预防小鼠移植物抗宿主病期间的移植物失败

Autophagy prevents graft failure during murine graft-versus-host disease.
PubMed 文献 · Blood Adv · 2024-01-01

该研究探讨自噬在异基因移植及移植物抗宿主病(GVHD)中对造血干细胞(HSC)适应性的贡献。体外实验显示肿瘤坏死因子和IL-1β协同促进HSC及造血祖细胞(HPC)自噬,体内实验显示GVHD期间供者HSC和HPC自噬增加。竞争性移植实验表明自噬缺陷细胞重建造血能力低于野生型;在主要组织相容性复合体错配GVHD模型中,自噬缺陷HSC和祖细胞无法建立持久造血,导致原发性移植物失败和普遍移植相关死亡。

要点

  • GVHD细胞因子风暴中的肿瘤坏死因子和IL-1β协同促进HSC和HPC自噬。
  • GVHD期间供者HSC和HPC自噬水平增加,且这些细胞依赖自噬存活。
  • 自噬缺陷HSC和祖细胞在GVHD模型中导致原发性移植物失败和普遍移植相关死亡。

核心结论

  • 自噬是异基因干细胞移植后HSC和祖细胞群体的关键生存机制,可能成为预防GVHD期间移植物失败的治疗靶点。

研究设计与样本

  • 研究采用体外实验、体内实验和竞争性移植实验,使用主要组织相容性复合体错配GVHD模型。

主要发现

  • 体外实验显示肿瘤坏死因子和IL-1β协同促进HSC及其更成熟HPC的自噬。
  • 体内实验显示GVHD期间供者HSC和HPC自噬增加。
  • 竞争性移植实验显示自噬缺陷细胞重建造血系统能力低于野生型对应细胞。
  • 在主要组织相容性复合体错配GVHD模型中,自噬缺陷HSC和祖细胞无法建立持久造血,导致原发性移植物失败和普遍移植相关死亡。
  • 多个模型证实,在T细胞来源炎性细胞因子存在下,早期祖细胞和HSC群体自噬活性增加,且这些HSC群体需要自噬才能存活。

关键数值与推荐

  • 原文未报告关键数值与推荐。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Autophagy is an intracellular survival process that has established roles in the long-term survival and function of hematopoietic stem cells (HSC). We investigated the contribution of autophagy to HSC fitness during allogeneic transplantation and graft-versus-host disease (GVHD). We demonstrate in vitro that both tumor necrosis factor and IL-1β, major components of GVHD cytokine storm, synergistically promote autophagy in both HSC and their more mature hematopoietic progenitor cells (HPC). In vivo we demonstrate that autophagy is increased in donor HSC and HPC during GVHD. Competitive transplant experiments demonstrated that autophagy-deficient cells display reduced capacity to reconstitute the hematopoietic system compared to wild-type counterparts. In a major histocompatibility complex-mismatched model of GVHD and associated cytokine dysregulation, we demonstrate that autophagy-deficient HSC and progenitors fail to establish durable hematopoiesis, leading to primary graft failure and universal transplant related mortality. Using several different models, we confirm that autophagy activity is increased in early progenitor and HSC populations in the presence of T-cell-derived inflammatory cytokines and that these HSC populations require autophagy to survive. Thus, autophagy serves as a key survival mechanism in HSC and progenitor populations after allogeneic stem cell transplant and may represent a therapeutic target to prevent graft failure during GVHD.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Lineburg KE, Leveque-El Mouttie L, Hunter CR, et al. Autophagy prevents graft failure during murine graft-versus-host disease. Blood Adv. 2024. PMID: 38295282. doi:10.1182/bloodadvances.2023010972

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。